180 related articles for article (PubMed ID: 16495230)
1. FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells.
Bunker JM; Kamath K; Wilson L; Jordan MA; Feinstein SC
J Biol Chem; 2006 Apr; 281(17):11856-63. PubMed ID: 16495230
[TBL] [Abstract][Full Text] [Related]
2. Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration.
Levy SF; Leboeuf AC; Massie MR; Jordan MA; Wilson L; Feinstein SC
J Biol Chem; 2005 Apr; 280(14):13520-8. PubMed ID: 15671021
[TBL] [Abstract][Full Text] [Related]
3. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.
Feinstein SC; Wilson L
Biochim Biophys Acta; 2005 Jan; 1739(2-3):268-79. PubMed ID: 15615645
[TBL] [Abstract][Full Text] [Related]
4. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation.
Sahara N; Tomiyama T; Mori H
J Neurosci Res; 2000 May; 60(3):380-7. PubMed ID: 10797541
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation.
Delobel P; Flament S; Hamdane M; Jakes R; Rousseau A; Delacourte A; Vilain JP; Goedert M; Buée L
J Biol Chem; 2002 Mar; 277(11):9199-205. PubMed ID: 11756436
[TBL] [Abstract][Full Text] [Related]
6. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
7. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.
Hasegawa M; Smith MJ; Goedert M
FEBS Lett; 1998 Oct; 437(3):207-10. PubMed ID: 9824291
[TBL] [Abstract][Full Text] [Related]
8. FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action.
LeBoeuf AC; Levy SF; Gaylord M; Bhattacharya A; Singh AK; Jordan MA; Wilson L; Feinstein SC
J Biol Chem; 2008 Dec; 283(52):36406-15. PubMed ID: 18940799
[TBL] [Abstract][Full Text] [Related]
9. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations.
Goedert M; Satumtira S; Jakes R; Smith MJ; Kamibayashi C; White CL; Sontag E
J Neurochem; 2000 Nov; 75(5):2155-62. PubMed ID: 11032905
[TBL] [Abstract][Full Text] [Related]
10. Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.
Bunker JM; Wilson L; Jordan MA; Feinstein SC
Mol Biol Cell; 2004 Jun; 15(6):2720-8. PubMed ID: 15020716
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease.
Goode BL; Chau M; Denis PE; Feinstein SC
J Biol Chem; 2000 Dec; 275(49):38182-9. PubMed ID: 10984497
[TBL] [Abstract][Full Text] [Related]
12. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.
Yotsumoto K; Saito T; Asada A; Oikawa T; Kimura T; Uchida C; Ishiguro K; Uchida T; Hasegawa M; Hisanaga SI
J Biol Chem; 2009 Jun; 284(25):16840-16847. PubMed ID: 19401603
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tau isoform expression and dementia.
D'Souza I; Schellenberg GD
Biochim Biophys Acta; 2005 Jan; 1739(2-3):104-15. PubMed ID: 15615630
[TBL] [Abstract][Full Text] [Related]
15. FTDP-17 Mutations Alter the Aggregation and Microtubule Stabilization Propensity of Tau in an Isoform-Specific Fashion.
Mutreja Y; Combs B; Gamblin TC
Biochemistry; 2019 Feb; 58(6):742-754. PubMed ID: 30562452
[TBL] [Abstract][Full Text] [Related]
16. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.
Hasegawa M; Smith MJ; Iijima M; Tabira T; Goedert M
FEBS Lett; 1999 Jan; 443(2):93-6. PubMed ID: 9989582
[TBL] [Abstract][Full Text] [Related]
17. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Matsumura N; Yamazaki T; Ihara Y
Am J Pathol; 1999 Jun; 154(6):1649-56. PubMed ID: 10362789
[TBL] [Abstract][Full Text] [Related]
18. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
Dawson HN; Cantillana V; Chen L; Vitek MP
J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
[TBL] [Abstract][Full Text] [Related]
19. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17.
Yen SH; Hutton M; DeTure M; Ko LW; Nacharaju P
Brain Pathol; 1999 Oct; 9(4):695-705. PubMed ID: 10517508
[TBL] [Abstract][Full Text] [Related]
20. Structural and microtubule binding properties of tau mutants of frontotemporal dementias.
Fischer D; Mukrasch MD; von Bergen M; Klos-Witkowska A; Biernat J; Griesinger C; Mandelkow E; Zweckstetter M
Biochemistry; 2007 Mar; 46(10):2574-82. PubMed ID: 17297915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
